Literature DB >> 29164382

CT texture features of liver parenchyma for predicting development of metastatic disease and overall survival in patients with colorectal cancer.

Scott J Lee1, Ryan Zea2,3, David H Kim2, Meghan G Lubner2, Dustin A Deming4, Perry J Pickhardt2.   

Abstract

OBJECTIVES: To determine if identifiable hepatic textural features are present at abdominal CT in patients with colorectal cancer (CRC) prior to the development of CT-detectable hepatic metastases.
METHODS: Four filtration-histogram texture features (standard deviation, skewness, entropy and kurtosis) were extracted from the liver parenchyma on portal venous phase CT images at staging and post-treatment surveillance. Surveillance scans corresponded to the last scan prior to the development of CT-detectable CRC liver metastases in 29 patients (median time interval, 6 months), and these were compared with interval-matched surveillance scans in 60 CRC patients who did not develop liver metastases. Predictive models of liver metastasis-free survival and overall survival were built using regularised Cox proportional hazards regression.
RESULTS: Texture features did not significantly differ between cases and controls. For Cox models using all features as predictors, all coefficients were shrunk to zero, suggesting no association between any CT texture features and outcomes. Prognostic indices derived from entropy features at surveillance CT incorrectly classified patients into risk groups for future liver metastases (p < 0.001).
CONCLUSIONS: On surveillance CT scans immediately prior to the development of CRC liver metastases, we found no evidence suggesting that changes in identifiable hepatic texture features were predictive of their development. KEY POINTS: • No correlation between liver texture features and metastasis-free survival was observed. • Liver texture features incorrectly classified patients into risk groups for liver metastases. • Standardised texture analysis workflows need to be developed to improve research reproducibility.

Entities:  

Keywords:  CT; CT texture analysis; Colorectal cancer; Colorectal metastases; Hepatic metastases

Mesh:

Year:  2017        PMID: 29164382     DOI: 10.1007/s00330-017-5111-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  22 in total

1.  Hypothesis testing II: means.

Authors:  Richard Tello; Philip E Crewson
Journal:  Radiology       Date:  2003-02-28       Impact factor: 11.105

2.  In search of biologic correlates for liver texture on portal-phase CT.

Authors:  Balaji Ganeshan; Kenneth A Miles; Rupert C D Young; Chris R Chatwin
Journal:  Acad Radiol       Date:  2007-09       Impact factor: 3.173

3.  Using cross-validation to evaluate predictive accuracy of survival risk classifiers based on high-dimensional data.

Authors:  Richard M Simon; Jyothi Subramanian; Ming-Chung Li; Supriya Menezes
Journal:  Brief Bioinform       Date:  2011-02-15       Impact factor: 11.622

4.  Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population.

Authors:  S Manfredi; A M Bouvier; C Lepage; C Hatem; V Dancourt; J Faivre
Journal:  Br J Surg       Date:  2006-09       Impact factor: 6.939

Review 5.  Characterization of PET/CT images using texture analysis: the past, the present… any future?

Authors:  Mathieu Hatt; Florent Tixier; Larry Pierce; Paul E Kinahan; Catherine Cheze Le Rest; Dimitris Visvikis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-06       Impact factor: 9.236

6.  Whole-liver CT texture analysis in colorectal cancer: Does the presence of liver metastases affect the texture of the remaining liver?

Authors:  Sheng-Xiang Rao; Doenja Mj Lambregts; Roald S Schnerr; Wenzel van Ommen; Thiemo Ja van Nijnatten; Milou H Martens; Luc A Heijnen; Walter H Backes; Cornelis Verhoef; Meng-Su Zeng; Geerard L Beets; Regina Gh Beets-Tan
Journal:  United European Gastroenterol J       Date:  2014-12       Impact factor: 4.623

7.  Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline.

Authors:  Christopher E Desch; Al B Benson; Mark R Somerfield; Patrick J Flynn; Carol Krause; Charles L Loprinzi; Bruce D Minsky; David G Pfister; Katherine S Virgo; Nicholas J Petrelli
Journal:  J Clin Oncol       Date:  2005-10-31       Impact factor: 44.544

8.  Regularization Paths for Generalized Linear Models via Coordinate Descent.

Authors:  Jerome Friedman; Trevor Hastie; Rob Tibshirani
Journal:  J Stat Softw       Date:  2010       Impact factor: 6.440

9.  External validation of a Cox prognostic model: principles and methods.

Authors:  Patrick Royston; Douglas G Altman
Journal:  BMC Med Res Methodol       Date:  2013-03-06       Impact factor: 4.615

10.  Radiomics: Images Are More than Pictures, They Are Data.

Authors:  Robert J Gillies; Paul E Kinahan; Hedvig Hricak
Journal:  Radiology       Date:  2015-11-18       Impact factor: 11.105

View more
  12 in total

1.  Computed tomography textural analysis for the differentiation of chronic lymphocytic leukemia and diffuse large B cell lymphoma of Richter syndrome.

Authors:  C P Reinert; B Federmann; J Hofmann; H Bösmüller; S Wirths; J Fritz; M Horger
Journal:  Eur Radiol       Date:  2019-06-24       Impact factor: 5.315

2.  Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapy.

Authors:  Marco Ravanelli; Giorgio Maria Agazzi; Elena Tononcelli; Elisa Roca; Paolo Cabassa; Gianluca Baiocchi; Alfredo Berruti; Roberto Maroldi; Davide Farina
Journal:  Radiol Med       Date:  2019-06-06       Impact factor: 3.469

3.  Establishment of a new non-invasive imaging prediction model for liver metastasis in colon cancer.

Authors:  Yu Li; Aydin Eresen; Junjie Shangguan; Jia Yang; Yun Lu; Dong Chen; Jian Wang; Yury Velichko; Vahid Yaghmai; Zhuoli Zhang
Journal:  Am J Cancer Res       Date:  2019-11-01       Impact factor: 6.166

Review 4.  The application of radiomics in predicting gene mutations in cancer.

Authors:  Yana Qi; Tingting Zhao; Mingyong Han
Journal:  Eur Radiol       Date:  2022-01-20       Impact factor: 5.315

5.  MRI-based radiomics nomogram to predict synchronous liver metastasis in primary rectal cancer patients.

Authors:  Minglu Liu; Xiaolu Ma; Fu Shen; Yuwei Xia; Yan Jia; Jianping Lu
Journal:  Cancer Med       Date:  2020-05-31       Impact factor: 4.452

6.  Application of Radiomics Analysis Based on CT Combined With Machine Learning in Diagnostic of Pancreatic Neuroendocrine Tumors Patient's Pathological Grades.

Authors:  Tao Zhang; YueHua Zhang; Xinglong Liu; Hanyue Xu; Chaoyue Chen; Xuan Zhou; Yichun Liu; Xuelei Ma
Journal:  Front Oncol       Date:  2021-02-11       Impact factor: 6.244

7.  Value of contrast-enhanced CT texture analysis in predicting IDH mutation status of intrahepatic cholangiocarcinoma.

Authors:  Yong Zhu; Yingfan Mao; Jun Chen; Yudong Qiu; Yue Guan; Zhongqiu Wang; Jian He
Journal:  Sci Rep       Date:  2021-03-25       Impact factor: 4.379

8.  Early Diagnosis of Liver Metastases from Colorectal Cancer through CT Radiomics and Formal Methods: A Pilot Study.

Authors:  Aldo Rocca; Maria Chiara Brunese; Antonella Santone; Pasquale Avella; Paolo Bianco; Andrea Scacchi; Mariano Scaglione; Fabio Bellifemine; Roberta Danzi; Giulia Varriano; Gianfranco Vallone; Fulvio Calise; Luca Brunese
Journal:  J Clin Med       Date:  2021-12-22       Impact factor: 4.241

Review 9.  Radiomics in liver diseases: Current progress and future opportunities.

Authors:  Jingwei Wei; Hanyu Jiang; Dongsheng Gu; Meng Niu; Fangfang Fu; Yuqi Han; Bin Song; Jie Tian
Journal:  Liver Int       Date:  2020-07-02       Impact factor: 5.828

10.  Radiomics-based model for predicting early recurrence of intrahepatic mass-forming cholangiocarcinoma after curative tumor resection.

Authors:  Yong Zhu; Yingfan Mao; Jun Chen; Yudong Qiu; Yue Guan; Zhongqiu Wang; Jian He
Journal:  Sci Rep       Date:  2021-09-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.